Cannabis Market by Product Type (Flower, Concentrates), Compound (THC-Dominant, CBD-Dominant, and Balanced THC & CBD), Application (Medical and Recreational), and Region (North America, South America, Europe, and Row) - Global Forecast to 2023
[149 Pages Report] Cannabis is a drug derived from the Cannabis Sativa, Cannabis Indica, and hybrid strains. The main cannabinoids that are most active are tetrahydrocannabinol (THC), the psychoactive compound, and cannabidiol (CBD). The market definition for cannabis, in this study, takes into consideration both medical as well as recreational cannabis.
The cannabis market is projected to grow at a CAGR of 30.7% to reach USD 39.35 billion by 2023 from USD 10.31 billion in 2018. The growth is attributed to the increasing number of medicinal applications of cannabis and the increasing legalization of cannabis. The complex regulatory structure for the usage of cannabis is restraining market growth.
By product type, the concentrates segment is expected to grow at the highest rate during the forecast period.
The flower segment dominated all the product types of cannabis. The dominance of this segment is mainly attributable to its maximum availability, and its method of delivery as smoking or vaping the cannabis flower has a quicker effect and is preferred for fast-acting relief by medical and recreational cannabis consumers.
The market for concentrates is projected to grow at the highest CAGR during the forecast period. This is due to their ease in usage, and their versatility in the method of delivery, such as dabbing, ingestible oils, and tinctures. Also, along with ingestion, concentrates can offer cleaner, smoother, and less odiferous hits than the flower.
By compound, the THC- dominant segment is expected to dominate the market during the forecast period.
The THC-dominant segment dominated the market for cannabis in 2017 and is also projected to grow at the highest CAGR during the forecast period. The dominance of this segment is majorly attributed to the fact that THC is the psychoactive substance in cannabis products, which is responsible for the high. Even though high THC content is better known for its mind-altering euphoria, it also has significant medical benefits. It is considered useful in relieving nausea, appetite loss, and insomnia, among other symptoms.
North America expected to lead the market during the forecast period.
The North American market accounted for the largest share in 2017. The market in this region is primarily driven by growth in the US and Canadian markets. The market in this region is driven by the increasing legalization of cannabis for both medical and recreational purposes. There is a growing awareness among consumers regarding the health benefits of cannabis. The market is further fuelled by the presence of major cannabis giants such as Canopy Growth Corporation, Aurora Cannabis Inc., and Medical Marijuana Inc., who are continuously investing and collaborating for the development of new products to fulfil the consumer demand.
Market Dynamics
Driver: Increasing legalization of cannabis
Cannabis legalization is often viewed upon with dual perceptions wherein its legalization has been met with scepticism associated with possible abuse. On the contrary, it is believed that legalization could, in turn, allow people to practice safe substance usage, while also reaping its medicinal benefits. As a result, there is an increasing number of countries that are gradually legalizing the usage of cannabis across the globe. As of November 2018, it is legal to smoke marijuana for medical usage in 33 states in the US, whereas nine states will still be requiring a doctors letter to do so. The recreational usage of cannabis is, in turn, legalized in ten of these states. Similarly, in 2013, Uruguay became the first country to legalize marijuana outside the US. Similarly, Canada, too, legalized the complete usage of marijuana in 2018.
While most countries across the globe have still not legalized the usage, the approach to the usage and sales has been relaxed over the years. As more countries move toward its partial or complete legalization, the market for cannabis will be experiencing a positive trajectory.
Restraint: Complex regulatory structure for the usage of cannabis
Companies offering cannabis and cannabis-infused products are required to comply with different regulatory guidelines globally. While countries across the globe practice different levels of legalization for different applications of marijuana, the strict regulatory norms about the production and sales of cannabis across various states in the same country could be tedious for manufacturers and stakeholders to comply with. Additionally, the regulations associated with a single application of cannabis also remain highly varied from state to state, which further leads to complications related to the trading of the commodity. For instance, Germany allows general practitioners to prescribe cannabis only when alternative treatment types cannot be applied to a medical condition. Also, many countries only allow the usage of specific cannabis compounds for treatment purposes. The UK is amongst the few countries that imply the usage of medical cannabis as illegal in nature, except for Nabilone and Sativex.
The complexity of regulations associated with the usage of cannabis is not only limited to the type of variation in regulations, but also remains highly ambiguous in nature. For instance, for both Washington DC and Vermont, the possession of cannabis is permitted up to specified limits, but its trade for recreational purposes remains restricted. Similarly, Chile allows the possession of a certain amount of cannabis, with the cultivation of about six plants. However, public consumption and trade are still not allowed. Furthermore, the regulations associated with the trading, manufacturing, and prescription of cannabis remains highly complex and varied across states and countries, which makes the industry one of the most highly regulated ones.
Opportunity: Product development via research and novel product delivery solutions
Robust growth in the global demand for cannabis has further propelled the need to come up with better product delivery systems as well as sustainable product strains. This need has, in turn, led to many companies coming up with R&D, which extensively investigates several genetic improvement strategies for cannabis. For instance, Hydro pothecary partnered with Segra in March 2018 to incorporate plant tissue propagation into the cannabis plant production process, to help increase the yield of healthy and better variant plants to serve the growing industry for medical and recreational cannabis. While looking into this genetic improvement, companies have been extensively venturing into the development of wide yielding varieties, better harvestability and market quality, a reliable low THC content, and improved herbicide tolerance of the cannabis crop. The high yield potential of cannabis arises from several factors that are both genetic and agronomic in nature. This would further investigate combining early maturity, and reduced plant height and acceptable seed size, to improve grain yield. The early maturity makes the harvest window more flexible, while a reduced plant height further aids this increase of the harvest window.
Challenge: Declining prices as product gets commoditized
Although the market for cannabis is expected to be experiencing exponential growth rates during the forecast period, crop pricing could highly hamper market development for cannabis. This could happen as more countries across the globe look forward to commoditizing cannabis, which, in turn, could result in crop prices experiencing a downward trend. While the legalization of cannabis could propel the market prospects during the short run when manufacturers and related stakeholders of the industry witness substantial demand. This upward wave may experience a slump in pricing due to various market forces creating a state of disequilibrium due to excess supply, the advent of an increased number of local and unorganized players, and market fragmentation. For instance, the legalization of recreational and medicinal cannabis in Canada has already resulted in the appreciation of shares of Aurora and Canopy by 200%, ridden by market sales hype, and an optimistic outlook. Furthermore, the expectations associated with the pricing of their product have also been over-estimated, with US private producers of cannabis earning about 60% lesser than what is expected of Canada. While the supply of marijuana to the market will be higher than market expectations, in comparison to the demand being lower, there will be a market state of oversupply. Furthermore, the government controls that limit all differentiating factors could further lead to commoditization, resulting in the reduction of commodity prices.
Scope of the Report
|
Report Metric |
Details |
|
Market size available for years |
20162023 |
|
Base year considered |
2017 |
|
Forecast period |
20182023 |
|
Forecast units |
Million (USD) |
|
Segments covered |
Product Type, Application, Compound, and Region |
|
Geographies covered |
North America, South America, Europe, and RoW |
|
Companies covered |
Key market players including, |
The research report categorizes the Cannabis Market to forecast the revenues and analyze the trends in each of the following sub-segments:
By product type,
- Flower
- Concentrates
- Others (capsules, topicals, edibles, and beverages)
By application
- Medical
- Recreational
By compound
- THC-dominant
- CBD-dominant
- Balanced THC & CBD
By region
- North America
- Us
- Canada
- Mexico
- South America
- Chile
- Columbia
- Uruguay
- Europe
- Germany
- Italy
- France
- The Netherlands
- RoW
Key Market Players
Canopy Growth Corporation (Canada), Aurora Cannabis Inc. (Canada), Cannabis Science Inc. (US), and Aphria Inc. (Canada)
Recent Developments
- In October 2018, Spectrum Cannabis (Canada), a wholly owned subsidiary of Canopy Growth Corporation, partnered with the Ontario Long Term Care Association (OLTCA) (Canada) for the pilot study on cannabis as an alternative source of medicine for degenerative cognitive function.
- In August 2018, Aurora Cannabis Inc. and its subsidiary MedReleaf Corp. (Canada), entered into an agreement with the Ontario Cannabis Store for the distribution of its high margin products such as pre-rolls, oils, and capsules.
- In August 2018, Terra Tech Corp. partnered with the Valiente Group (Germany), to manufacturer cannabis-infused non-alcoholic beverages under the brand IVXX.
- In July 2018, Aurora Cannabis Inc. announced to form a partnership with Wagner Dimas Inc. (Nevada). Under this partnership, both the companies would form a new entity for the production of pre-rolls using Wagner Dimas's technology to serve the recreational market.
Critical questions the report answers:
- What will be the revenue-generating pockets for the key players in the Cannabis Market?
- Which are the major players leading the market, and what initiatives have they undertaken over the past few years?
- What are the future revenue pockets in the market?
- How is the current regulatory framework expected to impact the market?
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Segmentation
1.4 Regions Covered
1.5 Periodization Considered
1.6 Currency Considered
1.7 Stakeholders
2 Research Methodology (Page No. - 19)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.3 Data Triangulation
2.4 Assumptions for the Study
2.5 Limitations of the Study
3 Executive Summary (Page No. - 27)
4 Premium Insights (Page No. - 32)
4.1 Attractive Opportunities in the Market
4.2 Market For Cannabis: Major Countries
4.3 Market For Cannabis in North America, by Product Type & Country
4.4 Market For Cannabis, by Application & Region
4.5 Market For Cannabis, by Compound & Region
5 Market Overview (Page No. - 36)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Medicinal Application of Cannabis
5.2.1.2 Increasing Legalization of Cannabis
5.2.2 Restraints
5.2.2.1 Complex Regulatory Structure for the Usage of Cannabis
5.2.3 Opportunities
5.2.3.1 Product Development Via Research and Novel Product Delivery Solutions
5.2.4 Challenges
5.2.4.1 Declining Prices as Product Gets Commoditized
5.3 Value Chain: Market for Cannabis
5.4 Global Regulatory Overview
5.5 Regulatory Overview, by Country
5.5.1 Us
5.5.1.1 Nevada
5.5.1.2 Colorado
5.5.1.3 Maine
5.5.1.4 California
5.5.1.5 Massachusetts
5.5.1.6 Alaska
5.5.1.7 Oregon
5.5.1.8 Washington
5.5.1.9 Washington DC
5.5.1.10 Vermont
5.5.2 Canada
5.5.3 Germany
5.5.4 Italy
5.5.5 Denmark
5.5.6 Czech Republic
5.5.7 Chile
5.5.8 Netherlands
5.5.9 Colombia
5.5.10 Uruguay
5.5.11 Australia
5.5.12 Israel
6 Market For Cannabis, by Product Type (Page No. - 46)
6.1 Introduction
6.2 Flower
6.2.1 Increasing Usage of Cannabis for Recreational Purposes is Expected to Fuel the Market Growth for These Products
6.3 Concentrates
6.3.1 A Wide Variety of Delivery Methods Have Made the Market for Cannabis Concentrates Extremely Favorable Amongst Consumers
6.4 Others
6.4.1 Large Number of Food & Beverage Manufacturing Companies Venturing Into the Cannabis-Infused Edibles Category Expected to Drive the Market Growth
7 Market For Cannabis, by Application (Page No. - 51)
7.1 Introduction
7.2 Medical
7.2.1 Increasing Usage of Cannabis for Pain, Neurological Health, and Mental Health Management is Driving the Market for Medical Cannabis
7.2.1.1 Pain Management
7.2.1.2 Neurological Health Management
7.2.1.3 Mental Health Management
7.2.1.4 Others
7.3 Recreational
7.3.1 Wider Legalization Status of Recreational Cannabis to Significantly Boost Market Growth
8 Market For Cannabis, by Compound (Page No. - 55)
8.1 Introduction
8.2 Tetrahydrocannabinol (THC)-Dominant
8.2.1 Increasing Legalization of Recreational Cannabis Could Help Propel the Market for THC-Dominant Cannabis Strains
8.3 Cannabidiol (CBD)-Dominant
8.3.1 Usage of Cannabidiol for Medicinal Applications is Driving the Market for CBD-Dominant Cannabis Products
8.4 Balanced THC & CBD
8.4.1 Balanced THC & CBD Strains Producing Effects, Which Help Diminish the Psychoactive Properties of THC, are Expected to Drive the Market Growth
9 Market For Cannabis, by Region (Page No. - 60)
9.1 Introduction
9.2 North America
9.2.1 Us
9.2.1.1 Growing Legalization of Both Medical and Recreational Cannabis in Several States to Drive the Market in the Us
9.2.2 Canada
9.2.2.1 Legalization of Recreational Cannabis to Drive the Market in Canada
9.2.3 Mexico
9.2.3.1 Legalization of Medical Cannabis to Drive the Mexican Market For Cannabis
9.3 South America
9.3.1 Chile
9.3.1.1 Increasing Awareness Among Consumers About the Benefits of Medical Cannabis in the Treatment of Chronic Pain, Seizures, and Nausea is Driving the Market in Chile
9.3.2 Colombia
9.3.2.1 A High Percentage of Population Suffering From Chronic Diseases is Driving the Colombian Cannabis Market
9.3.3 Uruguay
9.3.3.1 The Fully Legalized Cannabis Industry With Eased Regulations is Driving the Market For Cannabis in Uruguay
9.3.4 Rest of South America
9.3.4.1 Legalization of Medical Cannabis is the Major Driver for the Market in the Rest of South America
9.4 Europe
9.4.1 Germany
9.4.1.1 Complete Health Insurance Coverage for the Use of Medical Cannabis is Driving the German Market For Cannabis
9.4.2 Italy
9.4.2.1 Increase in Demand for Cannabis Coupled With the Issuance of Import Licenses to Drive Growth in the Italian Market For Cannabis
9.4.3 France
9.4.3.1 The Healthcare System in France is Driving the Market Growth
9.4.4 The Netherlands
9.4.4.1 Strong Supporting Infrastructure of Pharmacies is Driving the Market in the Netherlands
9.4.5 Rest of Europe
9.4.5.1 Legalization of Medical Cannabis is the Major Driver for the Market in the Rest of Europe
9.5 Rest of the World (RoW)
9.5.1 Israel
9.5.1.1 Agricultural & Technical Innovations Coupled With Liberal Government Policies to Drive the Cannabis Market in Israel
9.5.2 Australia
9.5.2.1 Improved Access to Medical Cannabis is Projected to Drive the Cannabis Market in Australia
10 Competitive Landscape (Page No. - 91)
10.1 Overview
10.2 Key Market Strategies
10.3 Ranking of Key Players, 2018
10.4 Investment Overview
10.5 Competitive Scenario
10.5.1 Agreements, Collaborations, Joint Ventures, and Partnerships
10.5.2 New Product Launches
10.5.3 Expansions & Investments
10.5.4 Acquisitions
11 Company Profiles (Page No. - 98)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis & MnM View)*
11.1 Canopy Growth Corporation
11.2 Aurora Cannabis Inc.
11.3 Medmen
11.4 Terra Tech Corp.
11.5 Aphria Inc.
11.6 Vivo Cannabis Inc.
11.7 Chronos Group Inc.
11.8 Medical Marijuana, Inc.
11.9 Stenocare
11.10 Tikun Olam
11.11 Organigrams Holding Inc.
11.12 Cannabis Science Inc.
11.13 Maricann Group Inc.
11.14 Tilray Inc
11.15 Hexo
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis & MnM View Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. - 143)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details
List of Tables (76 Tables)
Table 1 US Dollar Exchange Rates Considered, 20152018
Table 2 Cannabis Market Snapshot, 2018 vs 2023
Table 3 Cannabis Market Size, By Product Type, 20162023 (USD Million)
Table 4 Flower Market Size, By Region, 20162023 (USD Million)
Table 5 Concentrates Market Size, By Region, 20162023 (USD Million)
Table 6 Others Market Size, By Region, 20162023 (USD Million)
Table 7 Market For Cannabis Size, By Application, 20162023 (USD Million)
Table 8 Medical Market Size, By Region, 20162023 (USD Million)
Table 9 Recreational Market Size, By Region, 20162023 (USD Million)
Table 10 Market For Cannabis Size, By Compound, 20162023 (USD Million)
Table 11 THC-Dominant Market Size, By Region, 20162023 (USD Million)
Table 12 CBD-Dominant Market Size, By Region, 20162023 (USD Million)
Table 13 Balanced THC & CBD Market Size, By Region, 20162023 (USD Million)
Table 14 By Market Size, By Region, 20162023 (USD Million)
Table 15 North America: By Market Size, By Country, 20162023 (USD Million)
Table 16 North America: By Market Size, By Product Type, 20162023 (USD Million)
Table 17 North America: By Market Size, By Application, 20162023 (USD Million)
Table 18 North America: By Market Size, By Compound, 20162023 (USD Million)
Table 19 US: By Market Size, By Product Type, 20162023 (USD Million)
Table 20 US: By Market Size, By Application, 20162023 (USD Million)
Table 21 US: By Market Size, By Compound, 20162023 (USD Million)
Table 22 Canada: By Market Size, By Product Type, 20162023 (USD Million)
Table 23 Canada: By Market Size, By Application, 20162023 (USD Million)
Table 24 Canada: Cannabis Market Size, By Compound, 20162023 (USD Million)
Table 25 Mexico: Cannabis Market Size, By Product Type, 20162023 (USD Million)
Table 26 Mexico: By Market Size, By Application, 20162023 (USD Million)
Table 27 Mexico: By Market Size, By Compound, 20162023 (USD Million)
Table 28 South America: By Market Size, By Country, 20162023 (USD Million)
Table 29 South America: By Market Size, By Product Type, 20162023 (USD Million)
Table 30 South America: By Market Size, By Application, 20162023 (USD Million)
Table 31 South America: By Market Size, By Compound, 20162023 (USD Million)
Table 32 Chile: Cannabis Market Size, By Product Type, 20162023 (USD Million)
Table 33 Chile: By Market Size, By Application, 20162023 (USD Million)
Table 34 Chile: Cannabis Market Size, By Compound, 20162023 (USD Million)
Table 35 Colombia: Cannabis Market Size, By Product Type, 20162023 (USD Million)
Table 36 Colombia: By Market Size, By Application, 20162023 (USD Million)
Table 37 Colombia: By Market Size, By Compound, 20162023 (USD Million)
Table 38 Uruguay: Cannabis Market Size, By Product Type, 20162023 (USD Million)
Table 39 Uruguay: By Market Size, By Application, 20162023 (USD Million)
Table 40 Uruguay: By Market Size, By Compound, 20162023 (USD Million)
Table 41 Rest of South America: By Market Size, By Product Type, 20162023 (USD Million)
Table 42 Rest of South America: By Market Size, By Application, 20162023 (USD Million)
Table 43 Rest of South America: By Market Size, By Compound, 20162023 (USD Million)
Table 44 Europe: By Market Size, By Country, 20162023 (USD Million)
Table 45 Europe: By Market Size, By Product Type, 20162023 (USD Million)
Table 46 Europe: By Market Size, By Application, 20162023 (USD Million)
Table 47 Europe: Cannabis Market Size, By Compound, 20162023 (USD Million)
Table 48 Germany: By Market Size, By Product Type, 20162023 (USD Million)
Table 49 Germany: By Market Size, By Application, 20162023 (USD Million)
Table 50 Germany: By Market Size, By Compound, 20162023 (USD Million)
Table 51 Italy: By Market Size, By Product Type, 20162023 (USD Million)
Table 52 Italy: Cannabis Market Size, By Application, 20162023 (USD Million)
Table 53 Italy: By Market Size, By Compound, 20162023 (USD Million)
Table 54 France: By Market Size, By Product Type, 20162023 (USD Million)
Table 55 France: By Market Size, By Application, 20162023 (USD Million)
Table 56 France: Cannabis Market Size, By Compound, 20162023 (USD Million)
Table 57 The Netherlands: By Market Size, By Product Type, 20162023 (USD Million)
Table 58 The Netherlands: By Market Size, By Application, 20162023 (USD Million)
Table 59 The Netherlands: Cannabis Market Size, By Compound, 20162023 (USD Million)
Table 60 Rest of Europe: By Market Size, By Product Type, 20162023 (USD Million)
Table 61 Rest of Europe: By Market Size, By Application, 20162023 (USD Million)
Table 62 Rest of Europe: By Market Size, By Compound, 20162023 (USD Million)
Table 63 RoW: By Market Size, By Country, 2016-2023 (USD Million)
Table 64 RoW: By Market Size, By Product Type, 2016-2023 (USD Million)
Table 65 RoW: Cannabis Market Size, By Application, 20162023 (USD Million)
Table 66 RoW: By Market Size, By Compound, 2016-2023 (USD Million)
Table 67 Israel: By Market Size, By Product Type, 20162023 (USD Million)
Table 68 Israel: By Market Size, By Application, 20162023 (USD Million)
Table 69 Israel: Cannabis Market Size, By Compound, 20162023 (USD Million)
Table 70 Australia: By Market Size, By Product Type, 20162023 (USD Million)
Table 71 Australia: By Market Size, By Application, 20162023 (USD Million)
Table 72 Australia: By Market Size, By Compound, 20162023 (USD Million)
Table 73 Agreements, Collaborations, Joint Ventures, and Partnerships, 20132018
Table 74 New Product Launches, 20132018
Table 75 Expansions & Investments, 20132018
Table 76 Acquisitions, 20132018
List of Figures (44 Figures)
Figure 1 Cannabis Market: Research Design
Figure 2 Market For Cannabis: Bottom-Up Approach
Figure 3 Market For Cannabis: Top-Down Approach
Figure 4 Data Triangulation Methodology
Figure 5 By Market Size, By Product Type, 2018 vs 2023 (USD Million)
Figure 6 By Market Size, By Application, 2018 vs 2023 (USD Million)
Figure 7 By Market Size, By Compound, 2018 vs 2023 (USD Million)
Figure 8 By Market Share (Value), By Region, 2017
Figure 9 Growing Medicinal Application of Cannabis and Increasing Legalization of Cannabis to Drive the Demand for Cannabis
Figure 10 Germany to Grow at the Highest CAGR During the Forecast Period
Figure 11 US Accounted for the Largest Share of the North American Market for Cannabis in Terms of Country While the Flower Segment Dominated in Terms of Product Type in 2017
Figure 12 North America Dominated the Market Across Both Applications Through 2023
Figure 13 THC Dominant Segment to Grow at the Highest CAGR During the Forecast Period
Figure 14 Cannabis Market Dynamics
Figure 15 Value Chain: Cannabis Market
Figure 16 Global Cannabis Regulatory Overview Indicating Legality of Medical and Recreational Cannabis
Figure 17 New Revenue Pockets for the Market
Figure 18 US Cannabis Regulatory Overview
Figure 19 By Market Share, By Product Type, 2018 vs 2023
Figure 20 By Market Share, By Application, 2018 vs 2023
Figure 21 By Market Share, By Compound, 2018 vs 2023
Figure 22 US Accounted for the Largest Share of the Market for Cannabis in 2017
Figure 23 North America: Cannabis Market Snapshot
Figure 24 Europe: Cannabis Market Snapshot
Figure 25 Key Developments By Leading Players in the Market, 2013-2018
Figure 26 Number of Developments Between 2018 and 2016
Figure 27 Canopy Growth Corporation, Led the Market in 2018
Figure 28 Investment Overview
Figure 29 Canopy Growth Corporation: Company Snapshot
Figure 30 Canopy Growth Corporation: SWOT Analysis
Figure 31 Aurora Cannabis Inc.: Company Snapshot
Figure 32 Aurora Cannabis Inc.: SWOT Analysis
Figure 33 Medmen: Company Snapshot
Figure 34 Medmen: SWOT Analysis
Figure 35 Terra Tech Corp.: Company Snapshot
Figure 36 Terra Tech Corp.: SWOT Analysis
Figure 37 Aphria Inc.: Company Snapshot
Figure 38 Aphria Inc.: SWOT Analysis
Figure 39 Vivo Cannabis Inc.: Company Snapshot
Figure 40 Chronos Group Inc.: Company Snapshot
Figure 41 Medical Marijuana Inc.: Company Snapshot
Figure 42 Organigrams Holding Inc.: Company Snapshot
Figure 43 Maricann Group Inc. Growth: Company Snapshot
Figure 44 Hexo: Company Snapshot
Get in-depth analysis of the COVID-19 impact on the Cannabis Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Cannabis Market
Request For Special Pricing
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Cannabis Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Cannabis Market